Back

Increased levels of a collagen type-I degradation biomarker are predictive of mortality within 30-days and 1-year in patients admitted with ST-elevated myocardial infarction

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Acute heart failure - diagnostic methods 1 Biomarkers HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Ms Emily Martin

Nordic Bioscience, Herlev (Denmark)

6 More presentations in this session

Presentation thumbnail
Early feasibility study of a prototype device to non-invasively measure cardiac and pulmonary vascular pressures
Mr M. Mace (Helsingborg, SE)
Abstract Slides Video
Presentation thumbnail
The spot urine sodium-to-urine creatinine ratio outperforms urine sodium alone in the identification of patients with poor diuretic response in acute heart failure.
Mr G. Iwanek (Wroclaw, PL)
Abstract Slides Video
Presentation thumbnail
Bioimpedance spectroscopy evaluation of subclinical hypervolemia in heart failure patients: a comprehensive analysis
Doctor B. Braganca (Porto, PT)
Abstract Slides Video
Presentation thumbnail
Implementing an automated NT-proBNP linked heart failure referral and triage system in secondary care leads to increased heart failure specialist referral rates and reduced inpatient mortality.
Doctor M. Stanley (London, GB)
Abstract Slides Video
Presentation thumbnail
The optimal cut-off threshold of soluble suppressor of tumorigenicity 2 for prognostication in acute decompensated heart failure
Doctor B. Li (Basildon, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Acute heart failure - diagnostic methods 1

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Multi-biomarker approach for predicting cardiac magnetic resonance parameters at 30 days after ST-segment elevation myocardial infarction
thumbnail
Congress Presentation
Circulating NETosis markers in NSTEMI and predicting of 1-year cardiac death
thumbnail
Congress Presentation
Predictors of 1-year follow-up period MACE in patients with NSTEMI

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources